Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

228 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The effect of coenzyme Q10 in statin myopathy.
Zlatohlavek L, Vrablik M, Grauova B, Motykova E, Ceska R. Zlatohlavek L, et al. Neuro Endocrinol Lett. 2012;33 Suppl 2:98-101. Neuro Endocrinol Lett. 2012. PMID: 23183519 Clinical Trial.
Both fenofibrate and atorvastatin improve vascular reactivity in combined hyperlipidaemia (fenofibrate versus atorvastatin trial--FAT).
Malik J, Melenovsky V, Wichterle D, Haas T, Simek J, Ceska R, Hradec J. Malik J, et al. Cardiovasc Res. 2001 Nov;52(2):290-8. doi: 10.1016/s0008-6363(01)00382-0. Cardiovasc Res. 2001. PMID: 11684077 Clinical Trial.
Significant correlations (P<0.01) between the changes of vascular reactivity and biochemical indices were found between FMD and CRP (r=-0.60) and between both FMD and PBF, and insulinaemia (r=-0.48 and -0.56, respectively) only during treatment with fenofibrate. …
Significant correlations (P<0.01) between the changes of vascular reactivity and biochemical indices were found between FMD and CRP (r
Folate supplementation prevents plasma homocysteine increase after fenofibrate therapy.
Stulc T, Melenovský V, Grauová B, Kozich V, Ceska R. Stulc T, et al. Nutrition. 2001 Sep;17(9):721-3. doi: 10.1016/s0899-9007(01)00612-8. Nutrition. 2001. PMID: 11527658 Clinical Trial.
Impact of variants within seven candidate genes on statin treatment efficacy.
Vrablík M, Hubáček JA, Dlouhá D, Lánská V, Rynekrová J, Zlatohlávek L, Prusíková M, Ceška R, Adámková V. Vrablík M, et al. Physiol Res. 2012;61(6):609-17. doi: 10.33549/physiolres.932341. Epub 2012 Oct 25. Physiol Res. 2012. PMID: 23098650
Matrix metalloproteinases in isolated hypercholesterolemia.
Malik J, Stulc T, Ceska R. Malik J, et al. Int Angiol. 2005 Sep;24(3):300-3. Int Angiol. 2005. PMID: 16158043
Treatment of hypertriglyceridemia: a review of current options.
Vrablík M, Češka R. Vrablík M, et al. Physiol Res. 2015;64(Suppl 3):S331-40. doi: 10.33549/physiolres.933199. Physiol Res. 2015. PMID: 26680666 Review.
Statin-associated myopathy: from genetic predisposition to clinical management.
Vrablik M, Zlatohlavek L, Stulc T, Adamkova V, Prusikova M, Schwarzova L, Hubacek JA, Ceska R. Vrablik M, et al. Physiol Res. 2014;63 Suppl 3:S327-34. Physiol Res. 2014. PMID: 25428737 Review.
The use of statins in people at risk of developing diabetes mellitus: evidence and guidance for clinical practice.
Sattar NA, Ginsberg H, Ray K, Chapman MJ, Arca M, Averna M, Betteridge DJ, Bhatnagar D, Bilianou E, Carmena R, Ceška R, Corsini A, Erbel R, Flynn PD, Garcia-Moll X, Gumprecht J, Ishibashi S, Jambart S, Kastelein JJ, Maher V, da Silva PM, Masana L, Odawara M, Pedersen TR, Rotella CM, Salti I, Teramoto T, Tokgozoglu L, Toth PP, Valensi P, Vergès B. Sattar NA, et al. Atheroscler Suppl. 2014 Jun;15(1):1-15. doi: 10.1016/j.atherosclerosissup.2014.04.001. Atheroscler Suppl. 2014. PMID: 24840509 Review.
Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel.
Banach M, Rizzo M, Toth PP, Farnier M, Davidson MH, Al-Rasadi K, Aronow WS, Athyros V, Djuric DM, Ezhov MV, Greenfield RS, Hovingh GK, Kostner K, Serban C, Lighezan D, Fras Z, Moriarty PM, Muntner P, Goudev A, Ceska R, Nicholls SJ, Broncel M, Nikolic D, Pella D, Puri R, Rysz J, Wong ND, Bajnok L, Jones SR, Ray KK, Mikhailidis DP. Banach M, et al. Expert Opin Drug Saf. 2015 Jun;14(6):935-55. doi: 10.1517/14740338.2015.1039980. Epub 2015 Apr 24. Expert Opin Drug Saf. 2015. PMID: 25907232
Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial.
Nissen SE, Stroes E, Dent-Acosta RE, Rosenson RS, Lehman SJ, Sattar N, Preiss D, Bruckert E, Ceška R, Lepor N, Ballantyne CM, Gouni-Berthold I, Elliott M, Brennan DM, Wasserman SM, Somaratne R, Scott R, Stein EA; GAUSS-3 Investigators. Nissen SE, et al. JAMA. 2016 Apr 19;315(15):1580-90. doi: 10.1001/jama.2016.3608. JAMA. 2016. PMID: 27039291 Clinical Trial.
228 results
Jump to page
Feedback